Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH)

NCT01352026 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT01352026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01352026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Metformin Activity in Addition to Conventional Treatment of Grade II or III Pulmonary Arterial Hypertension (PAH)
Lead sponsor
Nantes University Hospital
Phase
Phase 2
Overall status
Withdrawn
Start date
May 31, 2011
Completion date
Not reported
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary arterial hypertension